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Introduction
Familial Mediterranean fever (FMF) is the most com-
mon of the hereditary autoinflammatory disorders. FMF
is caused by mutations of MEFV gene which encodes
for pyrin. It has been recently reported that frequency
of FMF-like symptoms decreases from patients carrying
two high penetrance mutations towards patients with a
single low penetrance mutation. The effectiveness of
interleukin (IL)-1b blockers has suggested that IL-1b
may play a role in the pathophysiology of the disease.
However, evidence of dysregulated IL-1b secretion in
FMF patients is so far missing. Moreover, the role of
NLRP3 has never been directly examined in FMF
patients.
Objectives
To define in patients affected by Familial Mediterranean
Fever (FMF), whether or not interleukin (IL)-1b secretion
(1) is enhanced, (2) correlates with the type of MEFV
mutation and (3) is mediated by NLRP3.
Methods
Freshly isolated monocytes from 20 FMF patients
(12 homozygous and 8 heterozygous), 14 MEFV healthy
carriers (HC) and 30 healthy donors (HD), unstimulated
or after LPS-induced activation, were analyzed for redox
state (reactive oxygen species (ROS) production and
antioxidant responses), and for IL-1b and IL-1Receptor
antagonist (IL-1Ra) secretion. NLRP3 down-modulation
was induced by NLRP3 in vitro silencing.
Results
LPS-stimulated monocytes from FMF patients displayed
enhanced IL-1b secretion which correlated with the
number and penetrance of MEFV mutations. Silencing
of NLRP3 consistently inhibited IL-1b secretion. As in
other autoinflammatory diseases, MEFV mutated mono-
cytes produced more ROS than genetically negative con-
trols. However, contrary to CAPS, they were featured by
a conserved and sustained antioxidant response. Consis-
tent with this finding, MEFV mutated monocytes did
not exhibit the functional indicators of oxidative stress
observed in CAPS, including accelerated IL-1b secretion
and deficient IL-1Ra production.
Conclusion
MEFV mutated monocytes display enhanced IL-1b
secretion which correlates with the number of high-
penetrance mutations and level of endogenous ROS.
Unlike NLRP3 mutated cells, monocytes carrying MEFV
mutations withstand oxidative stress and preserve
IL-1Ra production, thereby limiting inflammation.
Finally, in contrast to what found in the animal model,





1UO Pediatria II, G Gaslini IRCCS, Genoa, Italy. 2University of Genoa, Genoa,
Italy. 3UO Cell Biology, IRCCS AOU San Martino - IST, Genoa, Italy.
Published: 8 November 2013
doi:10.1186/1546-0096-11-S1-A104
Cite this article as: Omenetti et al.: OR7-003 – MEFV genotype, IL1B and
role of NLRP3 in FMF. Pediatric Rheumatology 2013 11(Suppl 1):A104.
1UO Pediatria II, G Gaslini IRCCS, Genoa, Italy
Full list of author information is available at the end of the article
Omenetti et al. Pediatric Rheumatology 2013, 11(Suppl 1):A104
http://www.ped-rheum.com/content/11/S1/A104
© 2013 Omenetti et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
